Nordwand Advisors »

Cortexyme shares owned by Nordwand Advisors

Quarter-by-quarter ownership of Cortexyme (QNCX) shares owned by Nordwand Advisors from 13F filings

Historical chart of Nordwand Advisors investment in Cortexyme

Tip: Access up to 7 years of quarterly data

All positions including Cortexyme held by Nordwand Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cortexyme by Nordwand Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.0k 20k 0.10

More positions owned by Nordwand Advisors

Vanguard Index Fds Large Cap Etf (VV)
Broadcom (AVGO)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Eaton Corp SHS (ETN)
Vertiv Holdings Com Cl A (VRT)
JPMorgan Chase & Co. (JPM)
Chevron Corporation (CVX)
Apple (AAPL)
Raytheon Technologies Corp (RTX)
Abbvie (ABBV)
Phillips 66 (PSX)
Ishares Tr Core S&p Scp Etf (IJR)
Oracle Corporation (ORCL)
Eli Lilly & Co. (LLY)

View all positions for Nordwand Advisors

Top funds holding Cortexyme

Woodline Partners
Millennium Management
Adage Capital Partners GP
Vanguard Group
Shay Capital
Acadian Asset Management
Ieq Capital
Superstring Capital Management
Renaissance Technologies
Marshall Wace
BlackRock
Vanguard Capital Management
Susquehanna International
Vanguard Fiduciary Trust
State Street Corporation

View all funds holding Cortexyme